news

Our latest
Press Releases & Updates

Latest press releases

RetinAI Discovery® platform and AI tools launched to improve decision workflows, referrals and patient management in Clinics for Ophthalmologists and Optometrists

Ikerian AG and RetinAI Inc. unveil RetinAI Discovery® for Clinics, revolutionizing eye care with AI-enhanced diagnostics and patient management for Ophthalmologists and Optometrists. This advanced platform streamlines clinical workflows and boosts patient engagement through innovative AI technology.

RetinAI Joins Forces with Stephen J. Ryan Initiative for Macular Research (RIMR) AMD Consortium to Forge a Global Retinal Imaging Initiative Targeting Research in AMD

RIMR members from around the world will now be able to connect through RetinAI’s cloud- based platform, RetinAI Discovery®, to facilitate a frictionless collaboration and derive insights on global AMD datasets, helping to advance research in this disease that is a leading cause of blindness in older individuals.

Joint Initiative to Precisely Target Patient Selection for PBM Therapy in Intermediate, Dry AMD Using RetinAI’s Discovery Platform

Discover how RetinAI's groundbreaking Discovery® platform and Gutblick's clinical expertise are joining forces to transform the future of eye care. Their collaboration focuses on harnessing AI technology for advanced research and clinical applications in managing Dry Age-related Macular Degeneration. This partnership signifies a leap forward in personalized treatment and care, setting new standards in ophthalmology.

RetinAI Announces Strategic Partnership with Eyestem to Innovate Geographic Atrophy Clinical Research Using State-of-the-Art AI Technology

Venture Kick Phase III [DECEMBER'17]

Early detection of eye diseases is key for effective treatment to reduce the onset of blindness. However, the patient’s journey to diagnosis is often long and involves many challenges. Venture Kick just awarded RetinAI with 130'000.- CHF to make eye care accessible and affordable to everyone via artificial intelligence.

Read more

5th Medtech & Digital Health Forum Basel [OCTOBER'17]

RetinAI participated in the latest edition of the 5th Medtech & Digital Health Forum in Basel. The team had the opportunity to present our current developments and efforts towards bringing Artificial Intelligence to Ophthalmology, specially in developing countries.

NVIDIA GTC Munich 2017 [OCTOBER'17]

RetinAI held a presentation during the last edition of the Nvidia GTC Europe in Munich, covering how ophthalmology is changing with Machine Learning. Stefanos Apostolopoulos (Technical Director) and Dr. Sandro De Zanet (Scientific Director) presented the efforts the company is doing to improve medical eye care around the world.

‍